Loading...

LNAI LUNAI BIOWORKS INC Management Changes 8-K Filing

LN B

LN

LUNAI BIOWORKS INC

(LNAI)

2025 8-K

Merger Completion

Special Meeting Postponed

Debt Exchange Agreements

Employee Furlough Announced

Delisting Notice

Delisting Notice

Sales Agreement Established

Equity Sale Agreement

Compliance Update

Shareholder Meeting Results

Delisting Notice

Compliance Regained

Stock Split Announcement

Bankruptcy Filing

Regulatory Compliance

Notification of Non-Compliance

Debt Restructuring

Merger Completion

Merger Agreement

Financial Restatement

CEO Agreement Update

CFO Appointment

Acquisition Agreement

CEO Appointment

COO Resignation

Director Appointments

Management Changes

Strategic Offering

Financial Misstatement

Resignation of Director

Private Placement

Amendment to Bylaws

Acquisition of Renovaro Cub...

Appointment of Interim CFO

Termination of License Agre...

Resignation of CFO

Equity Investment

Acquisitions and mergers

Amendment to Increase Autho...

Special Meeting of Stockhol...

Stock Purchase Agreement

Investor Presentation

Appointment and Advisory Ag...

Entry into Material Definit...

Board Appointments

Stock Purchase Agreement

Private Placement

Annual Meeting of Stockholders

Private Placement

Purchase Agreement with Lin...

Adjournment of Annual Meeting

Private Placement

Entry into Material Definit...

External Links:

Renovaro Inc. appointed Nathen Fuentes as Chief Financial Officer effective January 6, 2025, with a base salary of $280,000 and potential bonuses, while Simon Tarsh was removed from the interim CFO position.

AI Assistant

LUNAI BIOWORKS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.